Raymond Moniz

Company: Cue Biopharma

Job title: Associate Director- Discovery & Translational Immunology

Seminars:

Targeting IL-2 to tumor-specific T cells with novel biologic platforms 11:30 am

Generating a therapeutic index for IL-2 via selective delivery to tumor-specific T cells demonstrates anti-tumor activity in cancer patients Lead clinical candidate, CUE-101, provides clinical PoC and de-risking for the Immuno-STAT platform Novel bispecifics that can re-direct the protective viral T cell repertoire to destroy cancers – potential for superior safety and clinical efficacyRead more

day: Day One